PharmaCann and LivWell Enlightened Health Announce Planned Merger

PharmaCann and LivWell’s transformative partnership will create a combined portfolio of approximately 60 dispensary licenses and 11 cultivation and production facilities across 8 states

CHICAGO & DENVER–(BUSINESS WIRE)–PharmaCann Inc. (“PharmaCann”), the largest privately held, vertically integrated cannabis company in the United States, and LivWell Enlightened Health (“LivWell”), a multi-state cannabis cultivation and retail leader based in Colorado, today announced that they have entered into a definitive merger agreement pursuant to which PharmaCann will acquire LivWell Holdings, Inc.

“It is a privilege to join teams with LivWell, one of the longest tenured cannabis operators in the industry, with a shared commitment to improving people’s lives through cannabis,” said Brett Novey, CEO of PharmaCann. “This transformative merger significantly increases PharmaCann’s presence in the second and third largest cannabis markets in the U.S., and provides a strong foundational team and operational platform for PharmaCann’s further expansion into new states. Together we will implement best practices across all of our operations and build upon LivWell’s strong brand and expertise in producing low-cost, high-quality products.”

“We are excited for this partnership with a stalwart of the U.S. cannabis industry,” said John Lord, Founder and CEO of LivWell Enlightened Health. “PharmaCann’s undeniable financial expertise and LivWell’s proven operational leadership makes this merger the perfect combination to further the patient and customer experience on an expanding national level.”

Upon completion of the planned merger, PharmaCann and LivWell would operate approximately 60 dispensaries and 11 cultivation and production facilities across eight states. It is anticipated that John Lord will join the PharmaCann Board of Directors following the closing of the transaction.

The closing of the transaction is subject to customary closing conditions, including, among others, the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and state and municipal level regulatory approvals.

Canaccord Genuity Corp. served as financial advisor and Perkins Coie, LLP served as legal advisor to PharmaCann. Canaccord Genuity Corp. also provided a fairness opinion to the board of directors of PharmaCann.

Gramercy Capital Group, LLC (through INTE Securities LLC, member FINRA/SIPC) acted as exclusive financial advisor and Husch Blackwell LLP served as legal advisor to LivWell.

About PharmaCann

PharmaCann is the nation’s largest privately held and vertically integrated cannabis company, providing safe, reliable, and high-quality cannabis products, including its matter™ branded products, serving both the medical and adult-use markets. PharmaCann has a broad geographic footprint in the U.S. and has built an efficient, effective and scalable operating model, with dispensaries operating under the Verilife™ brand and cultivation and processing facilities across six limited license states: New York, Illinois, Ohio, Maryland, Pennsylvania and Massachusetts. For more information about PharmaCann, please visit: PharmaCann.com.

About LivWell Enlightened Health

Serving quality cannabis since 2009, the LivWell mission is to empower people to live life well. With careful tending and hard work, LivWell has grown from a single location to the nation’s most trusted multi-state cannabis company with operations in Colorado and Michigan. LivWell is a vertically integrated seed to sale cannabis retailer. In addition to cultivating cannabis, LivWell researches, extracts, and manufactures its own brands to consistently bring its customers quality products across multiple categories including topicals, edibles, tinctures, CBD pet tinctures, concentrates, and vaporizers. For more information about LivWell, please visit: LivWell.com.


  • Is CBD Right for Your Dog?
    “I am an advocate for CBD, but we succeed because our goal is to educate owners. We try to come from a place of science and personal experience. We do not believe in pressure selling CBD to anyone.”
  • Opinion: It’s time for action on adult-use cannabis in Pennsylvania
    National and local surveys of voters continue to reflect overwhelming support for legalization. Cannabis consumers are no longer asking for permission, instead we are demanding REAL reform at the ballot box. Politicians who make grand promises of cannabis reform should be on notice to start making good, or start looking for jobs in the private sector.
  • Virginia seals 64,000 marijuana distribution charges
    Officials said the records were scrubbed from the state’s criminal record database, which is used by employers like school boards, state agencies and local governments to screen employees.
  • Charlie Crist vows to push for legalizing cannabis as governor
    At a press conference in the state capital, Crist argued that the criminalization of marijuana has negatively impacted Floridians, therefore, he will push for “expungement of all existing charges and sentences for misdemeanors and third-degree felonies for marijuana possession.”
  • Nevada program to help BIPOC cannabis industry applicants
    Nevada’s cannabis rush following the legalization of recreational and medical marijuana saw the rise of another multibillion dollar industry that is predominantly owned and managed by white men. 
  • Judge blocks residency rule for Missouri medical cannabis licenses
    A federal judge last week permanently blocked Missouri from enforcing a requirement that medical marijuana licenses go to businesses owned by residents of the state.
  • SD adult-use cannabis initiative approved to gather signatures
    South Dakotans for Better Marijuana Laws, the group behind last year’s cannabis legalization push, announced yesterday that a new initiative has been approved for signature gathering.
  • Cannabis “tipping point” close, says Marijuana Policy Project head
    During a recent phone interview, Hawkins told Profiles in Legalization that he thinks half of U.S. states fully legalizing cannabis might be the “tipping point” into an end to federal cannabis prohibition.
  • Virginia medical cannabis patients see high prices and long waits
    Jenn Michelle Pedini, executive director of Virginia NORML, the state chapter of the National Organization for the Reform Marijuana Laws, noted the state’s decision to limit the program to five producers, who are only allowed to operate in the specific region of the state in which they are licensed.
  • MS activists rally around the state for medical cannabis laws
    House and Senate negotiators dickered most of the summer on a plan to replace the medical marijuana program the high court shot down. Reeves had said that if lawmakers could reach an agreement, he would call them into special session to pass it.